Boston Scientific (BSX) is up 4.1% after announcing the FDA has approved its Incepta, Energen,...

|About: Boston Scientific Corporation (BSX)|By:, SA News Editor

Boston Scientific (BSX) is up 4.1% after announcing the FDA has approved its Incepta, Energen, and Punctua defilibrator products, which it claims offer more battery life and greater portability than their predecessors. The company received approval for a heart stent product last week.